Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKG:2566)
Hong Kong · Delayed Price · Currency is HKD 9.59
-0.14 (-1.44%)
At close: Feb 13, 2026
HKG:2566 Market Cap
HKG:2566 has a market cap or net worth of 2.32 billion as of February 13, 2026. Its market cap has increased by 71.92% in one year.
Market Cap
2.32B
Enterprise Value
1.88B
Revenue
1.43B
Ranking
n/a
PE Ratio
16.09
Stock Price
9.59
Market Cap Chart
Since November 28, 2024, HKG:2566's market cap has increased from 1.88B to 2.32B, an increase of 23.38%. That is a compound annual growth rate of 18.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 2.35B | 26.67% |
| Dec 31, 2025 | 1.86B | 14.55% |
| Dec 31, 2024 | 1.62B | -13.73% |
| Nov 28, 2024 | 1.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medtide | 3.43B |
| BioDlink International Company | 3.25B |
| Jiangsu Recbio Technology | 3.05B |
| Clover Biopharmaceuticals | 2.89B |
| SinoMab BioScience | 2.48B |
| Antengene Corporation | 2.30B |
| Frontage Holdings | 2.19B |
| Mabpharm | 2.10B |